IOL Chemicals and Pharmaceuticals Ltd saw its shares jump 7% in morning trade after the company announced plans to consider a stock split during its board meeting on December 27. If approved, this would mark the company’s first-ever stock split, according to its exchange filing.
As per regulations, the trading window for insiders will remain closed from December 19 to December 29.
The Punjab-based specialty chemicals manufacturer recently received USFDA approval for its Ibuprofen manufacturing facility in Barnala, Punjab. This facility has also been certified by regulatory agencies like Brazil’s Anvisa, WHO, and Japan’s Ministry of Health, underscoring its global compliance standards.
As of 9:46 am, IOL Chemicals shares were trading 7.16% higher at Rs 435.00 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
